INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "TREATMENT OF HIDRADENITIS SUPPURATIVA USING ANTI-BAFF-R ANTIBODIES"

GENEVA, April 28 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2024/060241) for "TREATMENT OF HIDRADENITIS SUPPURATIVA USING ANTI-BAFF-R ANTIBODIES" on Oct 18, 2024. With publication no. WO/2025/083621, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BANG, Bo (Novartis Pharma AGLichtstrasse 354056 Basel), LOESCHE, Christian (Novartis Pharma AGLichtstrasse 354056 Basel)

Abstract: The disclosure relates to methods, treatment regimens, uses, kits and therapies for treating hidradenitis suppu...